BNP Paribas Exane re-initiated coverage of Sonova (SONVY) with an Underperform rating and CHF 195 price target The firm cites the company’s “weak” end markets and intense competition for the sell rating.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SONVY: